Consolidated Statements of Earnings - USD ($) shares in Thousands, $ in Millions		3 Months Ended
		Mar. 31, 2025	Mar. 31, 2024
Revenues:
Net earned premiums, principally supplemental health insurance	[1]	$ 3,381	$ 3,456
Net investment income		955	1,000
Net investment gains (losses)		(963)	951
Other income (loss)		25	29
Total revenues		3,398	5,436
Benefits and expenses:
Benefits and claims, excluding reserve remeasurement		1,986	2,066
Reserve remeasurement (gains) losses		(41)	(56)
Total benefits and claims, net		1,945	2,010
Acquisition and operating expenses:
Amortization of deferred policy acquisition costs		216	215
Insurance commissions		240	255
Insurance and other expenses		802	739
Interest expense		50	47
Total acquisition and operating expenses		1,308	1,256
Total benefits and expenses		3,253	3,266
Earnings before income taxes		145	2,170
Income taxes		116	291
Net earnings		$ 29	$ 1,879
Net earnings per share:
Basic (in dollars per share)		$ 0.05	$ 3.27
Diluted (in dollars per share)		$ 0.05	$ 3.25
Weighted-average outstanding common shares used in computing earnings per share (In thousands):
Basic (in shares)		544,707	574,886
Diluted (in shares)		546,878	577,482
Cash dividends per share		$ 0.58	$ 0.50

[1] Includes a gain (loss) of an immaterial amount and $(3) for the three-month periods ended March 31, 2025 and 2024, respectively, related to remeasurement of the deferred profit liability for limited-payment contracts.